{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:03:44Z","timestamp":1783487024429,"version":"3.55.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T00:00:00Z","timestamp":1462492800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NIH","award":["7R01FD003707"],"award-info":[{"award-number":["7R01FD003707"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s40618-016-0477-x","type":"journal-article","created":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T09:51:03Z","timestamp":1462528263000},"page":"1247-1257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Controversies in the management of Graves\u2019 disease in children"],"prefix":"10.1007","volume":"39","author":[{"given":"S. A.","family":"Rivkees","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,6]]},"reference":[{"key":"477_CR1","unstructured":"Conference Proceeding: Hepatic Toxicity Following Treatment for Pediatric Graves\u2019 Disease Meeting: October 28, 2008. Eunice Kennedy Shriver National Institute of Child Health and Human Development. http:\/\/bpca.nichd.nih.gov\/outreach\/index.cfm . Accessed Jan 14 2009"},{"issue":"3","key":"477_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40618-014-0214-2","volume":"38","author":"M Marino","year":"2015","unstructured":"Marino M, Latrofa F, Menconi F, Chiovato L, Vitti P (2015) Role of genetic and non-genetic factors in the etiology of Graves\u2019 disease. J Endocrinol Investig 38(3):283\u2013294. doi: 10.1007\/s40618-014-0214-2","journal-title":"J Endocrinol Investig"},{"issue":"11","key":"477_CR3","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1089\/thy.2007.0072","volume":"17","author":"J Smith","year":"2007","unstructured":"Smith J, Brown RS (2007) Persistence of thyrotropin (TSH) receptor antibodies in children and adolescents with Graves\u2019 disease treated using antithyroid medication. Thyroid 17(11):1103\u20131107","journal-title":"Thyroid"},{"issue":"11","key":"477_CR4","first-page":"3767","volume":"83","author":"SA Rivkees","year":"1998","unstructured":"Rivkees SA, Sklar C, Freemark M (1998) Clinical review 99: the management of Graves\u2019 disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 83(11):3767\u20133776","journal-title":"J Clin Endocrinol Metab"},{"key":"477_CR5","doi-asserted-by":"publisher","first-page":"249125","DOI":"10.1155\/2015\/249125","volume":"2015","author":"J Barrio-Barrio","year":"2015","unstructured":"Barrio-Barrio J, Sabater AL, Bonet-Farriol E, Velazquez-Villoria A, Galofre JC (2015) Graves\u2019 ophthalmopathy: VISA versus EUGOGO classification, assessment, and management. J Ophthalmol 2015:249125. doi: 10.1155\/2015\/249125","journal-title":"J Ophthalmol"},{"issue":"10","key":"477_CR6","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1055\/s-0035-1555762","volume":"47","author":"RS Bahn","year":"2015","unstructured":"Bahn RS (2015) Current insights into the pathogenesis of Graves\u2019 ophthalmopathy. Horm Metab Res 47(10):773\u2013778. doi: 10.1055\/s-0035-1555762","journal-title":"Horm Metab Res"},{"issue":"8","key":"477_CR7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s40618-014-0097-2","volume":"37","author":"L Bartalena","year":"2014","unstructured":"Bartalena L, Fatourechi V (2014) Extrathyroidal manifestations of Graves\u2019 disease: a 2014 update. J Endocrinol Investig 37(8):691\u2013700. doi: 10.1007\/s40618-014-0097-2","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"477_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1210\/jc.2011-1944","volume":"97","author":"J Leger","year":"2012","unstructured":"Leger J, Gelwane G, Kaguelidou F, Benmerad M, Alberti C (2012) Positive impact of long-term antithyroid drug treatment on the outcome of children with Graves\u2019 disease: national long-term cohort study. J Clin Endocrinol Metab 97(1):110\u2013119. doi: 10.1210\/jc.2011-1944","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"477_CR9","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1210\/jc.2008-0842","volume":"93","author":"F Kaguelidou","year":"2008","unstructured":"Kaguelidou F, Alberti C, Castanet M, Guitteny MA, Czernichow P, Leger J (2008) Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment. J Clin Endocrinol Metab 93(10):3817\u20133826","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"477_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000430985","volume":"84","author":"R Havgaard Kjaer","year":"2015","unstructured":"Havgaard Kjaer R, Smedegard Andersen M, Hansen D (2015) Increasing incidence of juvenile thyrotoxicosis in denmark: a nationwide study, 1998\u20132012. Horm Res Paediatr 84(2):102\u2013107. doi: 10.1159\/000430985","journal-title":"Horm Res Paediatr"},{"issue":"11\u201312","key":"477_CR11","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1515\/jpem-2013-0342","volume":"27","author":"G Jevalikar","year":"2014","unstructured":"Jevalikar G, Solis J, Zacharin M (2014) Long-term outcomes of pediatric Graves\u2019 disease. J Pediatr Endocrinol Metab 27(11\u201312):1131\u20131136. doi: 10.1515\/jpem-2013-0342","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"477_CR12","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1089\/thy.2012.0612","volume":"24","author":"H Ohye","year":"2014","unstructured":"Ohye H, Minagawa A, Noh JY, Mukasa K, Kunii Y, Watanabe N, Matsumoto M, Suzuki M, Yoshihara A, Ito K, Ito K (2014) Antithyroid drug treatment for graves\u2019 disease in children: a long-term retrospective study at a single institution. Thyroid 24(2):200\u2013207. doi: 10.1089\/thy.2012.0612","journal-title":"Thyroid"},{"issue":"6","key":"477_CR13","first-page":"1719","volume":"82","author":"NS Glaser","year":"1997","unstructured":"Glaser NS, Styne DM (1997) Predictors of early remission of hyperthyroidism in children. J Clin Endocrinol Metab 82(6):1719\u20131726","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"477_CR14","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1542\/peds.2007-1535","volume":"121","author":"NS Glaser","year":"2008","unstructured":"Glaser NS, Styne DM (2008) Predicting the likelihood of remission in children with Graves\u2019 disease: a prospective, multicenter study. Pediatrics 121(3):e481\u2013e488","journal-title":"Pediatrics"},{"issue":"5","key":"477_CR15","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1210\/jcem-60-5-1019","volume":"60","author":"JI Hamburger","year":"1985","unstructured":"Hamburger JI (1985) Management of hyperthyroidism in children and adolescents. J Clin Endocrinol Metab 60(5):1019\u20131024","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"477_CR16","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1210\/jcem-64-6-1241","volume":"64","author":"BM Lippe","year":"1987","unstructured":"Lippe BM, Landaw EM, Kaplan SA (1987) Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years. J Clin Endocrinol Metab 64(6):1241\u20131245","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"477_CR17","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1089\/thy.1997.7.755","volume":"7","author":"DI Shulman","year":"1997","unstructured":"Shulman DI, Muhar I, Jorgensen EV, Diamond FB, Bercu BB, Root AW (1997) Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid 7(5):755\u2013760","journal-title":"Thyroid"},{"issue":"15","key":"477_CR18","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1001\/jama.1983.03340150084036","volume":"250","author":"EM Chapman","year":"1983","unstructured":"Chapman EM (1983) History of the discovery and early use of radioactive iodine. JAMA 250(15):2042\u20132044","journal-title":"JAMA"},{"issue":"Suppl 1","key":"477_CR19","first-page":"114","volume":"59","author":"AP Weetman","year":"2003","unstructured":"Weetman AP (2003) Grave\u2019s disease 1835-2002. Horm Res 59(Suppl 1):114\u2013118","journal-title":"Horm Res"},{"issue":"9","key":"477_CR20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","volume":"352","author":"DS Cooper","year":"2005","unstructured":"Cooper DS (2005) Antithyroid drugs. N Engl J Med 352(9):905\u2013917","journal-title":"N Engl J Med"},{"issue":"1","key":"477_CR21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00002281-199801000-00007","volume":"10","author":"PA Merkel","year":"1998","unstructured":"Merkel PA (1998) Drugs associated with vasculitis. Curr Opin Rheumatol 10(1):45\u201350","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"477_CR22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0889-8529(05)70308-X","volume":"27","author":"DS Cooper","year":"1998","unstructured":"Cooper DS (1998) Antithyroid drugs for the treatment of hyperthyroidism caused by Graves\u2019 disease. Endocrinol Metab Clin North Am 27(1):225\u2013247","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"477_CR23","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/jc.2006-2135","volume":"92","author":"H Nakamura","year":"2007","unstructured":"Nakamura H, Noh JY, Itoh K, Fukata S, Miyauchi A, Hamada N (2007) Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves\u2019 disease. J Clin Endocrinol Metab 92(6):2157\u20132162","journal-title":"J Clin Endocrinol Metab"},{"key":"477_CR24","doi-asserted-by":"publisher","unstructured":"Rivkees SA (2010) 63 Years and 715 days to the \u201cBoxed Warning\u201d: unmasking of the propylthiouracil problem. Int J Pediatric Endocrinol vol. 2010, Article ID 658267, 3 pages, 2010. doi: 10.1155\/2010\/658267","DOI":"10.1155\/2010\/658267"},{"issue":"15","key":"477_CR25","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1056\/NEJMc0809750","volume":"360","author":"SA Rivkees","year":"2009","unstructured":"Rivkees SA, Mattison DR (2009) Ending propylthiouracil-induced liver failure in children. N Engl J Med 360(15):1574\u20131575. doi: 10.1056\/NEJMc0809750","journal-title":"N Engl J Med"},{"key":"477_CR26","unstructured":"Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII \u2013 Phase 2 (2006). National Academies Press, Washington D.C"},{"key":"477_CR27","doi-asserted-by":"publisher","first-page":"132041","DOI":"10.1155\/2009\/132041","volume":"2009","author":"SA Rivkees","year":"2009","unstructured":"Rivkees SA, Mattison DR (2009) Propylthiouracil (PTU) hepatoxicity in children and recommendations for discontinuation of use. Int J Pediatr Endocrinol 2009:132041. doi: 10.1155\/2009\/132041","journal-title":"Int J Pediatr Endocrinol"},{"issue":"7","key":"477_CR28","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1515\/JPEM.2000.13.7.879","volume":"13","author":"J Dotsch","year":"2000","unstructured":"Dotsch J, Siebler T, Hauffa BP, Doeker B, Andler W, Bettendorf M, Heinrich U, Gohlke B, Albers N, Willgerodt H, Kiess W (2000) Diagnosis and management of juvenile hyperthyroidism in Germany: a retrospective multicenter study. J Pediatric Endocrinol 13(7):879\u2013885","journal-title":"J Pediatric Endocrinol"},{"issue":"2","key":"477_CR29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00128072-200305020-00003","volume":"5","author":"J Dotsch","year":"2003","unstructured":"Dotsch J, Rascher W, Dorr HG (2003) Graves disease in childhood: a review of the options for diagnosis and treatment. Paediatr Drugs 5(2):95\u2013102","journal-title":"Paediatr Drugs"},{"issue":"6","key":"477_CR30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1515\/JPEM.2005.18.6.597","volume":"18","author":"AH Slyper","year":"2005","unstructured":"Slyper AH, Wyatt D, Boudreau C (2005) Effective methimazole dose for childhood Grave\u2019s disease and use of free triiodothyronine combined with concurrent thyroid-stimulating hormone level to identify mild hyperthyroidism and delayed pituitary recovery. J Pediatr Endocrinol Metab 18(6):597\u2013602","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"477_CR31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2265.2005.02415.x","volume":"64","author":"A Cassio","year":"2006","unstructured":"Cassio A, Corrias A, Gualandi S, Tato L, Cesaretti G, Volta C, Weber G, Bona G, Cappa M, Bal M, Bellone J, Cicognani A (2006) Influence of gender and pubertal stage at diagnosis on growth outcome in childhood thyrotoxicosis: results of a collaborative study. Clin Endocrinol (Oxf) 64(1):53\u201357","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"477_CR32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/thy.2006.0193","volume":"17","author":"H Sato","year":"2007","unstructured":"Sato H, Harada S, Yokoya S, Tanaka T, Asayama K, Mori M, Sasaki N (2007) Treatment for childhood-onset Graves\u2019 disease in Japan: results of a nationwide questionnaire survey of pediatric endocrinologists and thyroidologists. Thyroid 17(1):67\u201372","journal-title":"Thyroid"},{"issue":"9","key":"477_CR33","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/00007611-199509000-00018","volume":"88","author":"WC Nicholas","year":"1995","unstructured":"Nicholas WC, Fischer RG, Stevenson RA, Bass JD (1995) Single daily dose of methimazole compared to every 8 hours propylthiouracil in the treatment of hyperthyroidism. South Med J 88(9):973\u2013976","journal-title":"South Med J"},{"issue":"3","key":"477_CR34","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4158\/EP.17.3.456","volume":"17","author":"RS Bahn","year":"2011","unstructured":"Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN, American Thyroid A, American Association of Clinical E (2011) Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract 17(3):456\u2013520","journal-title":"Endocr Pract"},{"key":"477_CR35","doi-asserted-by":"crossref","unstructured":"Abraham P, Avenell A, Watson WA, Park CM, Bevan JS (2005) Antithyroid drug regimen for treating Graves\u2019 hyperthyroidism. Cochrane Database Syst Rev (2):CD003420","DOI":"10.1002\/14651858.CD003420.pub3"},{"issue":"6","key":"477_CR36","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/eje.1.02169","volume":"154","author":"S Razvi","year":"2006","unstructured":"Razvi S, Vaidya B, Perros P, Pearce SH (2006) What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves\u2019 disease. Eur J Endocrinol 154(6):783\u2013786","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"477_CR37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7326\/0003-4819-98-1-26","volume":"98","author":"DS Cooper","year":"1983","unstructured":"Cooper DS, Goldminz D, Levin AA, Ladenson PW, Daniels GH, Molitch ME, Ridgway EC (1983) Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med 98(1):26\u201329","journal-title":"Ann Intern Med"},{"issue":"3","key":"477_CR38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4158\/EP.8.3.222","volume":"8","author":"KA Woeber","year":"2002","unstructured":"Woeber KA (2002) Methimazole-induced hepatotoxicity. Endocr Pract 8(3):222\u2013224","journal-title":"Endocr Pract"},{"key":"477_CR39","doi-asserted-by":"publisher","first-page":"176970","DOI":"10.1155\/2010\/176970","volume":"2010","author":"SA Rivkees","year":"2010","unstructured":"Rivkees SA, Stephenson K, Dinauer C (2010) Adverse events associated with methimazole therapy of graves\u2019 disease in children. Int J Pediatr Endocrinol 2010:176970. doi: 10.1155\/2010\/176970","journal-title":"Int J Pediatr Endocrinol"},{"issue":"3","key":"477_CR40","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1089\/thy.2005.15.292","volume":"15","author":"J Tajiri","year":"2005","unstructured":"Tajiri J, Noguchi S (2005) Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy? Thyroid 15(3):292\u2013297","journal-title":"Thyroid"},{"key":"477_CR41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncpendmet0068","volume":"2","author":"AP Weetman","year":"2006","unstructured":"Weetman AP (2006) Graves\u2019 hyperthyroidism: how long should antithyroid drug therapy be continued to achieve remission? Nat Clin Pract Endocrinol Metab 2:2\u20133","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"3","key":"477_CR42","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1210\/jcem-70-3-675","volume":"70","author":"H Allannic","year":"1990","unstructured":"Allannic H, Fauchet R, Orgiazzi J, Madec AM, Genetet B, Lorcy Y, Le Guerrier AM, Delambre C, Derennes V (1990) Antithyroid drugs and Graves\u2019 disease: a prospective randomized evaluation of the efficacy of treatment duration. J Clin Endocrinol Metab 70(3):675\u2013679","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"477_CR43","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/BF03348811","volume":"15","author":"RV Garc\u00eda-Mayor","year":"1992","unstructured":"Garc\u00eda-Mayor RV, Paramo C, Cano RL, Mendez LP, Galofre JC, Andrade A (1992) Antithyroid drug and Graves\u2019 hyperthyroidism. Significance of treatment duration and TRAb determination on lasting remission. J Endocrinol Investig 15(11):815\u2013820","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"477_CR44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2265.1999.00629.x","volume":"50","author":"D Maugendre","year":"1999","unstructured":"Maugendre D, Gatel A, Campion L, Massart C, Guilhem I, Lorcy Y, Lescouarch J, Herry JY, Allannic H (1999) Antithyroid drugs and Graves\u2019 disease\u2014prospective randomized assessment of long-term treatment. Clin Endocrinol (Oxf) 50(1):127\u2013132","journal-title":"Clin Endocrinol (Oxf)"},{"key":"477_CR45","doi-asserted-by":"publisher","first-page":"165487","DOI":"10.1155\/2014\/165487","volume":"2014","author":"P Laurberg","year":"2014","unstructured":"Laurberg P, Nygaard B, Andersen S, Carle A, Karmisholt J, Krejbjerg A, Pedersen IB, Andersen SL (2014) Association between TSH-Receptor autoimmunity, hyperthyroidism, goitre, and orbitopathy in 208 patients included in the remission induction and sustenance in Graves\u2019 disease study. J Thyroid Res 2014:165487. doi: 10.1155\/2014\/165487","journal-title":"J Thyroid Res"},{"issue":"1","key":"477_CR46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1530\/EJE-07-0450","volume":"158","author":"P Laurberg","year":"2008","unstructured":"Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, Torring O (2008) TSH-receptor autoimmunity in Graves\u2019 disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol 158(1):69\u201375. doi: 10.1530\/EJE-07-0450","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"477_CR47","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1210\/jcem.85.10.6922","volume":"85","author":"L Lazar","year":"2000","unstructured":"Lazar L, Kalter-Leibovici O, Pertzelan A, Weintrob N, Josefsberg Z, Phillip M (2000) Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients. J Clin Endocrinol Metab 85(10):3678\u20133682","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"477_CR48","first-page":"1249","volume":"16","author":"L Gruneiro-Papendieck","year":"2003","unstructured":"Gruneiro-Papendieck L, Chiesa A, Finkielstain G, Heinrich JJ (2003) Pediatric Graves\u2019 disease: outcome and treatment. J Pediatr Endocrinol Metab 16(9):1249\u20131255","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"7","key":"477_CR49","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1089\/thy.2012.0568","volume":"23","author":"YK Chen","year":"2013","unstructured":"Chen YK, Lin CL, Chang YJ, Cheng FT, Peng CL, Sung FC, Cheng YH, Kao CH (2013) Cancer risk in patients with Graves\u2019 disease: a nationwide cohort study. Thyroid 23(7):879\u2013884. doi: 10.1089\/thy.2012.0568","journal-title":"Thyroid"},{"issue":"2","key":"477_CR50","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4158\/EP.6.2.221","volume":"6","author":"EL Mazzaferri","year":"2000","unstructured":"Mazzaferri EL (2000) Thyroid cancer and Graves\u2019 disease: the controversy ten years later. Endocr Pract 6(2):221\u2013225. doi: 10.4158\/EP.6.2.221","journal-title":"Endocr Pract"},{"issue":"4","key":"477_CR51","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jama.280.4.347","volume":"280","author":"E Ron","year":"1998","unstructured":"Ron E, Doody MM, Becker DV, Brill AB, Curtis RE, Goldman MB, Harris BS 3rd, Hoffman DA, McConahey WM, Maxon HR, Preston-Martin S, Warshauer ME, Wong FL, Boice JD Jr (1998) Cancer mortality following treatment for adult hyperthyroidism. Cooperative thyrotoxicosis therapy follow-up study group. JAMA 280(4):347\u2013355","journal-title":"JAMA"},{"key":"477_CR52","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1210\/jcem-38-6-976","volume":"38","author":"BM Dobyns","year":"1974","unstructured":"Dobyns BM, Sheline GE, Workman JB, Tompkins EA, McConahey WM, Becker DV (1974) Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study. J Clin Endocrinol Metab 38:976\u2013998","journal-title":"J Clin Endocrinol Metab"},{"key":"477_CR53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jama.280.4.347","volume":"280","author":"E Ron","year":"1998","unstructured":"Ron E, Doody Becker DV, Brill Curtis, Goldman Harris B, Hoffman McConahey, Maxon Preston-Martin, Warshauer Wong, Boice JDJ (1998) Cancer mortality following treatment for adult hyperthyroidism. Cooperative thyrotoxicosis therapy follow-up study group. JAMA 280:347\u2013355","journal-title":"JAMA"},{"issue":"6","key":"477_CR54","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2265.2004.02029.x","volume":"60","author":"L Harper","year":"2004","unstructured":"Harper L, Chin L, Daykin J, Allahabadia A, Heward J, Gough SC, Savage CO, Franklyn JA (2004) Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves\u2019 disease. Clin Endocrinol (Oxf) 60(6):671\u2013675","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"477_CR55","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/ard.61.1.90","volume":"61","author":"M Guma","year":"2002","unstructured":"Guma M, Olive A, Juan M, Salinas I (2002) ANCA antibodies in Graves\u2019 disease. Ann Rheum Dis 61(1):90\u201391","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"477_CR56","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/08916930400022673","volume":"38","author":"A Radice","year":"2005","unstructured":"Radice A, Sinico RA (2005) Antineutrophil cytoplasmic antibodies (ANCA). Autoimmunity 38(1):93\u2013103","journal-title":"Autoimmunity"},{"issue":"5","key":"477_CR57","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jadohealth.2011.03.005","volume":"49","author":"EG Marshall","year":"2011","unstructured":"Marshall EG (2011) Do young adults have unmet healthcare needs? J Adolesc Health 49(5):490\u2013497. doi: 10.1016\/j.jadohealth.2011.03.005","journal-title":"J Adolesc Health"},{"issue":"4","key":"477_CR58","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1054-139X(04)00100-4","volume":"35","author":"Society for Adolescent M","year":"2004","unstructured":"Society for Adolescent M (2004) Access to health care for adolescents and young adults. J Adolesc Health 35(4):342\u2013344","journal-title":"J Adolesc Health"},{"issue":"7","key":"477_CR59","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1089\/thy.2009.0169","volume":"19","author":"RS Bahn","year":"2009","unstructured":"Bahn RS, Burch HS, Cooper DS, Garber JR, Greenlee CM, Klein IL, Laurberg P, McDougall IR, Rivkees SA, Ross D, Sosa JA, Stan MN (2009) The role of propylthiouracil in the management of Graves\u2019 disease in adults: report of a meeting jointly sponsored by the American thyroid association and the food and drug administration. Thyroid 19(7):673\u2013674. doi: 10.1089\/thy.2009.0169","journal-title":"Thyroid"},{"issue":"4","key":"477_CR60","doi-asserted-by":"publisher","first-page":"713","DOI":"10.4158\/Ep10065.Co","volume":"16","author":"BE Hertz","year":"2010","unstructured":"Hertz BE, Schuller KE (2010) Saul Hertz, Md (1905\u20131950): a pioneer in the use of radioactive iodine. Endocrine Pract 16(4):713\u2013715. doi: 10.4158\/Ep10065.Co","journal-title":"Endocrine Pract"},{"key":"477_CR61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1210\/jcem-22-1-8","volume":"22","author":"GE Sheline","year":"1962","unstructured":"Sheline GE, McCormack KR, Galante M (1962) Thyroid nodules occurring late after treatment of thryotoxicosis with radioiodine. J Clin Endocrinol Metab 22:8\u201317","journal-title":"J Clin Endocrinol Metab"},{"key":"477_CR62","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1259\/0007-1285-36-425-340","volume":"36","author":"AWG Goolden","year":"1963","unstructured":"Goolden AWG, Davey JB (1963) The ablation of normal thyroid tissue with iodine-131. Br J Radiol 36:340\u2013345","journal-title":"Br J Radiol"},{"key":"477_CR63","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJM198310203091601","volume":"309","author":"HR Maxon","year":"1983","unstructured":"Maxon HR, Thomas SR, Hertzberg VS, Kereiakes JG, Chen IW, Sperling MI, Saenger EL (1983) Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med 309:937\u2013941","journal-title":"N Engl J Med"},{"key":"477_CR64","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3949\/ccjm.55.4.373","volume":"55","author":"WM Levy","year":"1988","unstructured":"Levy WM, Schumacher OP, Gupta M (1988) Treatment of childhood Graves\u2019 disease. A review with emphasis on radioiodine treatment. Cleveland Clin J Med 55:373\u2013382","journal-title":"Cleveland Clin J Med"},{"issue":"2","key":"477_CR65","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/thy.1997.7.247","volume":"7","author":"H Peters","year":"1997","unstructured":"Peters H, Fischer C, Bogner U, Reiners C, Schleusener H (1997) Treatment of Graves\u2019 hyperthyroidism with radioiodine: results of a prospective randomized study. Thyroid 7(2):247\u2013251","journal-title":"Thyroid"},{"key":"477_CR66","doi-asserted-by":"crossref","first-page":"900","DOI":"10.7326\/0003-4819-105-6-900","volume":"105","author":"GD Graham","year":"1986","unstructured":"Graham GD, Burman KD (1986) Radioiodine treatment of Graves\u2019 disease. An assessment of its potential risks. Ann Intern Med 105:900\u2013905","journal-title":"Ann Intern Med"},{"issue":"1","key":"477_CR67","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1067\/mpd.2002.125494","volume":"141","author":"TD Nebesio","year":"2002","unstructured":"Nebesio TD, Siddiqui AR, Pescovitz OH, Eugster EA (2002) Time course to hypothyroidism after fixed-dose radioablation therapy of Graves\u2019 disease in children. J Pediatr 141(1):99\u2013103","journal-title":"J Pediatr"},{"issue":"3","key":"477_CR68","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1210\/jc.2002-021801","volume":"88","author":"JE Kalinyak","year":"2003","unstructured":"Kalinyak JE, McDougall IR (2003) How should the dose of iodine-131 be determined in the treatment of Graves\u2019 hyperthyroidism? J Clin Endocrinol Metab 88(3):975\u2013977","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"477_CR69","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jc.2002-020805","volume":"88","author":"WD Leslie","year":"2003","unstructured":"Leslie WD, Ward L, Salamon EA, Ludwig S, Rowe RC, Cowden EA (2003) A randomized comparison of radioiodine doses in Graves\u2019 hyperthyroidism. J Clin Endocrinol Metab 88(3):978\u2013983","journal-title":"J Clin Endocrinol Metab"},{"issue":"4 Pt 1","key":"477_CR70","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1542\/peds.111.4.745","volume":"111","author":"SA Rivkees","year":"2003","unstructured":"Rivkees SA, Cornelius EA (2003) Influence of iodine-131 dose on the outcome of hyperthyroidism in children. Pediatrics 111(4 Pt 1):745\u2013749","journal-title":"Pediatrics"},{"issue":"4","key":"477_CR71","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3949\/ccjm.55.4.373","volume":"55","author":"WJ Levy","year":"1988","unstructured":"Levy WJ, Schumacher OP, Gupta M (1988) Treatment of childhood Graves\u2019 disease. A review with emphasis on radioiodine treatment. Cleveland Clin J Med 55(4):373\u2013382","journal-title":"Cleveland Clin J Med"},{"issue":"5","key":"477_CR72","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1210\/jcem.86.5.7473","volume":"86","author":"PM Kadmon","year":"2001","unstructured":"Kadmon PM, Noto RB, Boney CM, Goodwin G, Gruppuso PA (2001) Thyroid storm in a child following radioactive iodine (RAI) therapy: a consequence of RAI versus withdrawal of antithyroid medication. J Clin Endocrinol Metab 86(5):1865\u20131867","journal-title":"J Clin Endocrinol Metab"},{"key":"477_CR73","doi-asserted-by":"publisher","first-page":"212","DOI":"10.12659\/AJCR.890366","volume":"15","author":"HJ Rohrs 3rd","year":"2014","unstructured":"Rohrs HJ 3rd, Silverstein JH, Weinstein DA, Amdur RJ, Haller MJ (2014) Thyroid storm following radioactive iodine (RAI) therapy for pediatric graves disease. Am J Case Rep 15:212\u2013215. doi: 10.12659\/AJCR.890366","journal-title":"Am J Case Rep"},{"key":"477_CR74","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0001-2998(71)81039-5","volume":"1","author":"DV Becker","year":"1971","unstructured":"Becker DV, Hurly (1971) Complications of radioiodine treatment of hyperthyroidism. Semin Nucl Med 1:442\u2013460","journal-title":"Semin Nucl Med"},{"key":"477_CR75","first-page":"23","volume":"21","author":"S Refetoff","year":"1977","unstructured":"Refetoff S, Demeester-Mirkine N, Ermans AM, De Groot LJ (1977) Rapid control of thyrotoxicosis with combined 131I, anthithyroid drugs and KI therapy. J Nucl Med Allied Sci 21:23\u201329","journal-title":"J Nucl Med Allied Sci"},{"key":"477_CR76","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1210\/jcem-57-2-250","volume":"57","author":"DS Ross","year":"1983","unstructured":"Ross DS, Daniels GH, De Stefano P, Maloof F, Ridgway EC (1983) Use of adjunctive potassium iodide after radioactive iodine (131I) treatment of Graves\u2019 hyperthyroidism. J Clin Endocrinol Metab 57:250\u2013253","journal-title":"J Clin Endocrinol Metab"},{"key":"477_CR77","first-page":"81","volume":"5","author":"P Starr","year":"1964","unstructured":"Starr P, Jaffe HL, Oettinger L (1964) Late results of 131I treatment of hyperthyroidism in 73 children and adoloscents. J Nucl Med 5:81\u201389","journal-title":"J Nucl Med"},{"key":"477_CR78","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJM196502042720501","volume":"272","author":"MD Kogut","year":"1965","unstructured":"Kogut MD, Kaplan SA, Collipp PJ, Tiamsic T, Boyle D (1965) Treatment of hyperthyroidism in children: analysis of fourty-five patients. N Engl J Med 272:217\u2013222","journal-title":"N Engl J Med"},{"key":"477_CR79","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archpedi.1965.02090030525002","volume":"110","author":"G Crile","year":"1965","unstructured":"Crile G, Schumacher OP (1965) Radioactive iodine treatment of Graves\u2019 disease. Results in 32 children under 16\u00a0years of age. Am J Dis Child 110:501\u2013504","journal-title":"Am J Dis Child"},{"key":"477_CR80","first-page":"586","volume":"10","author":"HJ Starr","year":"1969","unstructured":"Starr HJ, Oettinger L (1969) Later results of 131-I treatment of hyperthyroidism in 73 children and adolescence: 1967 follow-up. J Nucl Med 10:586\u2013590","journal-title":"J Nucl Med"},{"key":"477_CR81","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJM197010292831802","volume":"283","author":"A Hayek","year":"1970","unstructured":"Hayek A, Chapman EM, Crawford JD (1970) Long term results of treatment of thyrotoxicosis in children and adolescents with radioactive iodine (131I) for hyperthyroidism. N Engl J Med 283:949\u2013953","journal-title":"N Engl J Med"},{"key":"477_CR82","first-page":"847","volume":"20","author":"JE Freitas","year":"1979","unstructured":"Freitas JE, Swanson DP, Gross MD, Sisson JC (1979) Iodine131-I: optimal therapy for thyroidism in children and adolescents? J Nucl Med 20:847\u2013850","journal-title":"J Nucl Med"},{"key":"477_CR83","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/00007611-199710000-00008","volume":"90","author":"BRP Moll","year":"1997","unstructured":"Moll BRP (1997) Pediatric Graves\u2019 disease: therapeutic options and experinence with radioiodine at the University of Mississippi Medical center. South Med J 90:1017\u20131022","journal-title":"South Med J"},{"key":"477_CR84","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1056\/NEJM197501232920401","volume":"292","author":"AM Safa","year":"1975","unstructured":"Safa AM, Schumacher OP, Rodriguez-Antunez A (1975) Long-term follow-up results in children and adolescents treated with radioactive iodine (131I) for hyperthyroidism. N Engl J Med 292:167\u2013171","journal-title":"N Engl J Med"},{"issue":"3","key":"477_CR85","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2362.1995.tb01547.x","volume":"25","author":"H Peters","year":"1995","unstructured":"Peters H, Fischer C, Bogner U, Reiners C, Schleusener H (1995) Radioiodine therapy of Graves\u2019 hyperthyroidism: standard vs. calculated 131 iodine activity. Results from a prospective, randomized, multicentre study. Eur J Clin Investig 25(3):186\u2013193","journal-title":"Eur J Clin Investig"},{"issue":"1","key":"477_CR86","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2362.1996.98243.x","volume":"26","author":"H Peters","year":"1996","unstructured":"Peters H, Fischer C, Bogner U, Reiners C, Schleusener H (1996) Reduction in thyroid volume after radioiodine therapy of Graves\u2019 hyperthyroidism: results of a prospective, randomized, multicentre study. Eur J Clin Investig 26(1):59\u201363","journal-title":"Eur J Clin Investig"},{"key":"477_CR87","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archinte.1975.00330050047007","volume":"135","author":"AM Safa","year":"1975","unstructured":"Safa AM (1975) Treatment of hyperthyroidism with a large initial dose of sodium iodine I 131. Arch Intern Med 135:673\u2013675","journal-title":"Arch Intern Med"},{"key":"477_CR88","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0022-3476(77)80843-3","volume":"91","author":"HV Barnes","year":"1977","unstructured":"Barnes HV, Blizzard RM (1977) Antithyroid drug therapy for toxic diffuse goiter (Graves disease): thirty years experience in children and adolscence. J Pediatr 91:313\u2013320","journal-title":"J Pediatr"},{"issue":"6","key":"477_CR89","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0039-6060(96)80049-3","volume":"120","author":"P Miccoli","year":"1996","unstructured":"Miccoli P, Vitti P, Rago T, Iacconi P, Bartalena L, Bogazzi F, Fiore E, Valeriano R, Chiovato L, Rocchi R, Pinchera A (1996) Surgical treatment of Graves\u2019 disease: subtotal or total thyroidectomy? Surgery 120(6):1020\u20131024 discussion 1024\u20131025","journal-title":"Surgery"},{"key":"477_CR90","first-page":"460","volume":"17","author":"SD Sarkar","year":"1976","unstructured":"Sarkar SD, Beierwaltes WH, Gill SP, Cowley BJ (1976) Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer. J Nucl Med 17:460\u2013464","journal-title":"J Nucl Med"},{"issue":"10","key":"477_CR91","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/jnci\/dji151","volume":"97","author":"JD Boice Jr","year":"2005","unstructured":"Boice JD Jr (2005) Radiation-induced thyroid cancer\u2013what\u2019s new? J Natl Cancer Instig 97(10):703\u2013705","journal-title":"J Natl Cancer Instig"},{"issue":"9","key":"477_CR92","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jama.295.9.1060","volume":"295","author":"JD Boice Jr","year":"2006","unstructured":"Boice JD Jr (2006) Thyroid disease 60\u00a0years after Hiroshima and 20\u00a0years after Chernobyl. JAMA 295(9):1060\u20131062","journal-title":"JAMA"},{"key":"477_CR93","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2307\/3579003","volume":"141","author":"E Ron","year":"1995","unstructured":"Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD Jr (1995) Thyroid Cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141:259\u2013277","journal-title":"Radiat Res"},{"key":"477_CR94","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00004032-196809000-00002","volume":"15","author":"GW Dolphin","year":"1968","unstructured":"Dolphin GW (1968) The risk of thyroid cancers following irradiation. Health Phys 15:219\u2013228","journal-title":"Health Phys"},{"issue":"9476","key":"477_CR95","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/S0140-6736(05)66695-0","volume":"365","author":"AJ Sigurdson","year":"2005","unstructured":"Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, Berkow RL, Hammond S, Neglia JP, Meadows AT, Sklar CA, Robison LL, Inskip PD (2005) Primary thyroid cancer after a first tumour in childhood (the childhood cancer survivor study): a nested case-control study. Lancet 365(9476):2014\u20132023","journal-title":"Lancet"},{"key":"477_CR96","first-page":"2283","volume":"50","author":"RRM Goldman","year":"1990","unstructured":"Goldman RRM, Maloof F (1990) Cancer mortality in women with thyroid disease. Cancer Res 50:2283\u20132289","journal-title":"Cancer Res"},{"key":"477_CR97","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/83.15.1072","volume":"83","author":"LE Holm","year":"1991","unstructured":"Holm LE, Hall P, Wiklund K, Lundell G, Berg G, Bjelkengren G, Cederquist E, Ericsson UB, Hallquist A, Larsson LG (1991) Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst 83:1072\u20131077","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"477_CR98","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJM199803123381103","volume":"338","author":"JA Franklyn","year":"1998","unstructured":"Franklyn JA, Maisonneuve P, Sheppard MC, Betteridge J, Boyle P (1998) Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med 338(11):712\u2013718","journal-title":"N Engl J Med"},{"issue":"1","key":"477_CR99","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.294.1.71","volume":"294","author":"JA Franklyn","year":"2005","unstructured":"Franklyn JA, Sheppard MC, Maisonneuve P (2005) Thyroid function and mortality in patients treated for hyperthyroidism. JAMA 294(1):71\u201380","journal-title":"JAMA"},{"issue":"6","key":"477_CR100","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1210\/jc.2005-1833","volume":"91","author":"RW Flynn","year":"2006","unstructured":"Flynn RW, Macdonald TM, Jung RT, Morris AD, Leese GP (2006) Mortality and vascular outcomes in patients treated for thyroid dysfunction. J Clin Endocrinol Metab 91(6):2159\u20132164","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"477_CR101","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/cncr.22635","volume":"109","author":"S Metso","year":"2007","unstructured":"Metso S, Auvinen A, Huhtala H, Salmi J, Oksala H, Jaatinen P (2007) Increased cancer incidence after radioiodine treatment for hyperthyroidism. Cancer 109(10):1972\u20131979","journal-title":"Cancer"},{"issue":"9","key":"477_CR102","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1210\/jc.2003-031223","volume":"89","author":"CH Read Jr","year":"2004","unstructured":"Read CH Jr, Tansey MJ, Menda Y (2004) A thirty-six year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' pateints. J Clin Endocrinol Metab 89(9):4229\u20134233","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"477_CR103","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1148\/radiographics.20.2.g00mc33533","volume":"20","author":"RE Toohey","year":"2000","unstructured":"Toohey RE, Stabin MG, Watson EE (2000) The AAPM\/RSNA physics tutorial for residents: internal radiation dosimetry: principles and applications. Radiographics 20(2):533\u2013546","journal-title":"Radiographics"},{"key":"477_CR104","unstructured":"Toohey RE, Stabin MG (1996) Comparative analysis of dosimetry parameters for nuclear medicine. ORISE Report 99-1064, 1999. In: Proceedings of the sixth international radiopharmaceutical dosimetry symposium, Gatlinburg, TN, 1996. pp 532\u2013551"},{"key":"477_CR105","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archotol.1977.00780260074010","volume":"103","author":"T Ching","year":"1977","unstructured":"Ching T, Warden MJ, Fefferman RA (1977) Thyroid surgery in children and teenagers. Arch Otolaryngol 103:544\u2013546","journal-title":"Arch Otolaryngol"},{"issue":"2","key":"477_CR106","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/archpedi.1981.02130260004003","volume":"135","author":"BA Buckingham","year":"1981","unstructured":"Buckingham BA, Costin G, Roe TF, Weitzman JJ, Kogut MD (1981) Hyperthyroidism in children. A reevaluation of treatment. Am J Dis Child 135(2):112\u2013117","journal-title":"Am J Dis Child"},{"key":"477_CR107","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1530\/eje.0.1340710","volume":"134","author":"Johansson H Rudberg","year":"1996","unstructured":"Rudberg Johansson H, Akerstrom G, Tuvemo Karlsson FA (1996) Graves\u2019 disease in children and adolescents. Late results of surgical treatment. Eur J Endocrinol 134:710\u2013715","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"477_CR108","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1210\/jc.2008-0660","volume":"93","author":"JA Sosa","year":"2008","unstructured":"Sosa JA, Tuggle CT, Wang TS, Thomas DC, Boudourakis L, Rivkees S, Roman SA (2008) Clinical and economic outcomes of thyroid and parathyroid surgery in children. J Clin Endocrinol Metab 93(8):3058\u20133065","journal-title":"J Clin Endocrinol Metab"},{"key":"477_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1687-9856-2013-1","volume":"1","author":"CK Breuer","year":"2013","unstructured":"Breuer CK, Solomon D, Donovan P, Rivkees SA (2013) Udelsman R (2013) Effect of patient Age on surgical outcomes for Graves\u2019 disease: a case-control study of 100 consecutive patients at a high volume thyroid surgical center. Int J Pediatr Endocrinol 1:1. doi: 10.1186\/1687-9856-2013-1","journal-title":"Int J Pediatr Endocrinol"},{"issue":"6","key":"477_CR110","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1089\/thy.2005.15.569","volume":"15","author":"G Lal","year":"2005","unstructured":"Lal G, Ituarte P, Kebebew E, Siperstein A, Duh QY, Clark OH (2005) Should total thyroidectomy become the preferred procedure for surgical management of Graves\u2019 disease? Thyroid 15(6):569\u2013574","journal-title":"Thyroid"},{"issue":"3","key":"477_CR111","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.suc.2004.01.006","volume":"84","author":"MS Boger","year":"2004","unstructured":"Boger MS, Perrier ND (2004) Advantages and disadvantages of surgical therapy and optimal extent of thyroidectomy for the treatment of hyperthyroidism. Surg Clin North Am 84(3):849\u2013874","journal-title":"Surg Clin North Am"},{"issue":"11","key":"477_CR112","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s002680010216","volume":"24","author":"J Witte","year":"2000","unstructured":"Witte J, Goretzki PE, Dotzenrath C, Simon D, Felis P, Neubauer M, Roher HD (2000) Surgery for Graves\u2019 disease: total versus subtotal thyroidectomy-results of a prospective randomized trial. World J Surg 24(11):1303\u20131311","journal-title":"World J Surg"},{"issue":"3","key":"477_CR113","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00000658-199809000-00005","volume":"228","author":"JA Sosa","year":"1998","unstructured":"Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R (1998) The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 228(3):320\u2013330","journal-title":"Ann Surg"},{"issue":"Suppl 1","key":"477_CR114","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4274\/jcrpe.817","volume":"5","author":"C Breuer","year":"2013","unstructured":"Breuer C, Tuggle C, Solomon D, Sosa JA (2013) Pediatric thyroid disease: when is surgery necessary, and who should be operating on our children? J Clin Res Pediatric Endocrinol 5(Suppl 1):79\u201385. doi: 10.4274\/jcrpe.817","journal-title":"J Clin Res Pediatric Endocrinol"},{"issue":"6","key":"477_CR115","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00383-012-3095-5","volume":"28","author":"E Peroni","year":"2012","unstructured":"Peroni E, Angiolini MR, Vigone MC, Mari G, Chiumello G, Beretta E, Weber G (2012) Surgical management of pediatric Graves\u2019 disease: an effective definitive treatment. Pediatr Surg Int 28(6):609\u2013614. doi: 10.1007\/s00383-012-3095-5","journal-title":"Pediatr Surg Int"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-016-0477-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-016-0477-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-016-0477-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-016-0477-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T06:47:23Z","timestamp":1567838843000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-016-0477-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,6]]},"references-count":115,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["477"],"URL":"https:\/\/doi.org\/10.1007\/s40618-016-0477-x","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,6]]}}}